Insider at

04

Insider transactions

05
1 buys (P) 17 sells (S) Net: $-19,172,642 + 50 non-open-market transactions below Avg return of open purchases vs now: 1.7% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

50 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 30, 2026 XENE P 30,000 $37.38 $1,121,400 49,923 Direct +150.58% Acquired 1.7% (price as of 2026-10-02)
March 13, 2026 XENE S 10b5-1 7,308 $55.22 $403,548 19,923 Direct -26.84% Disposed -31.1% (price as of 2026-10-02)
March 10, 2026 XENE S 10b5-1 11,269 $60.11 $677,380 14,731 Direct -43.34% Disposed -36.7% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 65,000 $62.06 $4,033,900 6,000 Direct -91.55% Disposed -38.7% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 61,652 $60.08 $3,704,052 6,000 Direct -91.13% Disposed -36.7% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 43,348 $59.26 $2,568,802 72,652 Direct -37.37% Disposed -35.8% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 2,449 $61.26 $150,026 6,000 Direct -28.99% Disposed -37.9% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 10,072 $60.47 $609,054 8,449 Direct -54.38% Disposed -37.1% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 12,479 $59.50 $742,500 18,521 Direct -40.25% Disposed -36.1% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 21,515 $60.49 $1,301,442 6,000 Direct -78.19% Disposed -37.1% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 31,694 $59.88 $1,897,837 27,515 Direct -53.53% Disposed -36.5% (price as of 2026-10-02)
March 9, 2026 XENE S 10b5-1 21,791 $58.81 $1,281,529 59,209 Direct -26.90% Disposed -35.4% (price as of 2026-10-02)
Jan. 2, 2026 XENE S 10b5-1 2,062 $44.93 $92,646 6,000 Direct -25.58% Disposed -15.4% (price as of 2026-10-02)
Jan. 2, 2026 XENE S 10b5-1 37,938 $44.40 $1,684,447 8,062 Direct -82.47% Disposed -14.4% (price as of 2026-10-02)
Dec. 8, 2025 XENE S 10b5-1 2,010 $46.32 $93,103 6,000 Direct -25.09% Disposed -17.9% (price as of 2026-10-02)
Dec. 8, 2025 XENE S 10b5-1 8,820 $45.59 $402,104 8,010 Direct -52.41% Disposed -16.6% (price as of 2026-10-02)
Dec. 5, 2025 XENE S 10b5-1 14,375 $45.03 $647,306 16,830 Direct -46.07% Disposed -15.6% (price as of 2026-10-02)
Nov. 28, 2025 XENE S 10b5-1 97 $45.01 $4,366 31,205 Direct -0.31% Disposed -15.5% (price as of 2026-10-02)
Oct. 1, 2025 XENE S 10b5-1 25,000 $40.16 $1,004,000 31,302 Direct -44.40% Disposed -5.3% (price as of 2026-10-02)
Jan. 27, 2025 XENE S 10b5-1 1,149 $41.07 $47,189 31,302 Direct -3.54% Disposed -7.4% (price as of 2026-10-02)
Jan. 27, 2025 XENE S 10b5-1 15,166 $40.46 $613,616 31,302 Direct -32.64% Disposed -6.0% (price as of 2026-10-02)
Jan. 24, 2025 XENE S 10b5-1 22,468 $40.20 $903,214 31,302 Direct -41.79% Disposed -5.4% (price as of 2026-10-02)
Jan. 23, 2025 XENE S 10b5-1 16,217 $40.08 $649,977 31,302 Direct -34.13% Disposed -5.1% (price as of 2026-10-02)
May 24, 2023 XENE S 1,407 $41.49 $58,376 31,302 Direct -4.30% Disposed -8.4% (price as of 2026-10-02)
May 24, 2023 XENE S 13,179 $41.37 $545,215 27,708 Direct -32.23% Disposed -8.1% (price as of 2026-10-02)
May 24, 2023 XENE S 17,069 $41.44 $707,339 24,213 Direct -41.35% Disposed -8.3% (price as of 2026-10-02)
Aug. 10, 2017 XENE P 10,000 $2.90 $29,000 14,300 Indirect +232.56% Acquired 1211.0% (price as of 2026-10-02)
Aug. 10, 2017 XENE P 5,000 $2.84 $14,200 6,000 Direct +500.00% Acquired 1238.7% (price as of 2026-10-02)
June 24, 2016 XENE P 1,300 $6.30 $8,190 4,300 Indirect +43.33% Acquired 503.5% (price as of 2026-10-02)
June 24, 2016 XENE P 2,000 $6.25 $12,500 3,000 Indirect +200.00% Acquired 508.3% (price as of 2026-10-02)
June 24, 2016 XENE P 1,000 $6.10 $6,100 1,000 Indirect · Acquired 523.3% (price as of 2026-10-02)
June 24, 2016 XENE P 1,000 $6.15 $6,150 1,000 Direct · Acquired 518.2% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 12, 2026 XENE Restricted Share Units Common Shares (12,500) · · 12,500 Disposed
March 9, 2026 XENE Performance Share Units Common Shares (20,000) · · 20,000 Disposed
March 9, 2026 XENE Performance Share Units Common Shares (20,000) · · 20,000 Acquired
March 9, 2026 XENE Stock Option Common Shares (65,000) $9.44 Sept. 15, 2029 65,000 Disposed
March 9, 2026 XENE Stock Option Common Shares (105,000) $4.75 March 11, 2028 105,000 Disposed
March 9, 2026 XENE Stock Option Common Shares (25,000) $3.10 Oct. 22, 2027 25,000 Disposed
March 9, 2026 XENE Stock Option Common Shares (75,000) $8.40 March 12, 2027 75,000 Disposed
Jan. 9, 2026 XENE Restricted Share Units Common Shares (65,000) $0.00 · 65,000 Acquired
Jan. 9, 2026 XENE Share Option (Right to Buy) Common Shares (350,000) $42.15 Jan. 8, 2036 350,000 Acquired
Jan. 2, 2026 XENE Stock Option (Right to Buy) Common Shares (40,000) $7.49 March 10, 2026 40,000 Disposed
Oct. 1, 2025 XENE Stock Option (Right to Buy) Common Shares (25,000) $7.69 Dec. 17, 2025 25,000 Disposed
March 12, 2025 XENE Restricted Share Units Common Shares (50,000) $0.00 · 50,000 Acquired
March 12, 2025 XENE Share Option (Right to Buy) Common Shares (275,000) $35.48 March 11, 2035 275,000 Acquired
Jan. 27, 2025 XENE Stock Option (Right to Buy) Common Shares (16,315) $17.76 March 16, 2025 16,315 Disposed
Jan. 24, 2025 XENE Stock Option (Right to Buy) Common Shares (22,468) $17.76 March 16, 2025 22,468 Disposed
Jan. 23, 2025 XENE Stock Option (Right to Buy) Common Shares (16,217) $17.76 March 16, 2025 16,217 Disposed
March 11, 2024 XENE Stock Option (Right to Buy) Common Shares (250,000) $44.37 March 10, 2034 250,000 Acquired
May 24, 2023 XENE Stock Option (Right to Buy) Common Shares (6,172) · Jan. 13, 2024 6,172 Disposed
May 24, 2023 XENE Stock Option (Right to Buy) Common Shares (20,576) · Jan. 13, 2024 20,576 Disposed
May 24, 2023 XENE Stock Option (Right to Buy) Common Shares (42,592) · July 31, 2023 42,592 Disposed
March 10, 2023 XENE Stock Option (Right to Buy) Common Shares (380,000) $34.18 March 9, 2033 380,000 Acquired
March 10, 2022 XENE Stock Option (Right to Buy) Common Shares (400,000) $30.01 March 9, 2032 400,000 Acquired
June 3, 2021 XENE Stock Option (Right to Buy) Common Shares (125,000) $18.56 June 2, 2031 125,000 Acquired
March 12, 2021 XENE Stock Option (Right to Buy) Common Shares (100,000) $20.55 March 11, 2031 100,000 Acquired
March 12, 2020 XENE Stock Option (Right to Buy) Common Shares (145,000) $11.58 March 11, 2030 145,000 Acquired
Sept. 16, 2019 XENE Stock Option (Right to Buy) Common Shares (135,000) $9.44 Sept. 15, 2029 135,000 Acquired
March 12, 2018 XENE Stock Option (Right to Buy) Common Shares (105,000) $4.75 March 11, 2028 105,000 Acquired
Oct. 23, 2017 XENE Stock Option (Right to Buy) Common Shares (25,000) $3.10 Oct. 22, 2027 25,000 Acquired
March 13, 2017 XENE Stock Option (Right to Buy) Common Shares (75,000) $8.40 March 12, 2027 75,000 Acquired
March 11, 2016 XENE Stock Option (Right to Buy) Common Shares (40,000) $7.49 March 10, 2026 40,000 Acquired
Dec. 18, 2015 XENE Stock Option (Right to Buy) Common Shares (25,000) $7.69 Dec. 17, 2025 25,000 Acquired
March 17, 2015 XENE Stock Option (Right to Buy) Common Shares (55,000) $17.76 March 16, 2025 55,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares · Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares · Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares · Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2014 $281,763 · · · $112,705 · $17,252 $587,822

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.